CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Beijing Succeeder Technology Inc Company Snapshot
Beijing Succeeder Technology Inc operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Beijing Succeeder Technology Inc with three other pharmaceutical manufacturers in Asia: Mizuho Medy Co Ltd of JAPAN (2020 sales of 4.21 billion Japanese Yen [US$38.48 million] of which 100% was Pharmaceutical Business), Kainos Laboratories, Inc. of JAPAN (4.61 billion Japanese Yen [US$42.18 million] of which 100% was sales business of clinical diagnostics), and Genereach Biotechnology Corp which is based in TAIWAN (857.03 million Taiwanese Dollars [US$30.66 million] of which 69% was Taiwan).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Beijing Succeeder Technology Inc
  Stock Performance Chart for Beijing Succeeder Technology Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (5/14/2021): 50.90
(Figures in Chinese Renmimbi)
1 Week 3.1%   13 Weeks 1.4%  
4 Weeks 5.8%   52 Weeks n/a  
 
Beijing Succeeder Technology Inc Key Data:
  Ticker: 688338 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2020 Sales 222,398,393
(Year Ending Jan 2021).
Employees: 282
  Currency: Chinese Renmimbi Market Cap: 4,155,883,200
  Fiscal Yr Ends: December Shares Outstanding: 81,648,000
  Share Type: GU Closely Held Shares: N/A
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.